Country - Belgium
Summary - Speed Up The Access To And/Or Uptake Of Innovative Mpox Vaccines
Deadline - Feb 18, 2026
MT reference number - 103579598
Product classification - Research and development services and related consultancy services
Address - Belgium
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 103579598
Document Type - Tender Notices
Description - Description: The subject of this call for tenders is the evaluation of the immunogenicity of a booster dose, including different routes of administration (intradermal vs. subcutaneous) and the appropriate timing of the booster dose, for the Modified Vaccinia Ankara - Bavarian Nordic Vector (MVA-BN) vaccine.The services to be provided shall include the conduct of scientific study(s)/clinical trial(s) addressing the opinions of the CT-CM Group (Clinical Trial Coordination Mechanism subgroup of the HERA Board) on the most urgent clinical trial needs for medical countermeasures against Mpox.In particular, the services to be contracted shall take into account the Group's advice on priority clinic
Mt Ref Id - 103579598
Deadline - Feb 18, 2026
Similar Tenders :
Healthcare and Medicine